As global healthcare enters a new cycle of “efficiency and trust,” Green Nature Medicine Chain (GNM) announced that it has entered the final sprint phase for its global launch. Jointly initiated by the RWA Life Science and Health Development Foundation (RWA) in the United States and GNM Technology Pte. Ltd. (Singapore), GNM is positioned as a “graphene-based RWA life and health public chain.” The project aims to achieve “equipment certifiability, data ownership verifiability, and asset settlement,” building an open, transparent, and sustainable life and health value network for institutions and individuals.
Project Origin
As healthcare spending continues to rise, the industry faces structural challenges such as data fragmentation, high collaboration costs, and slow value return. GNM’s mission is to integrate engineered user experiences with verifiable value loops: using graphene technology to create real, quantifiable everyday scenarios, blockchain to implement ownership confirmation and collaboration rules, and RWA (Real World Assets) to standardize the mapping and circulation of rights, driving the industry from “informatization” to “trusted assetization.”
GNM integrates its entire stack through a “triple coupling”: materials (graphene) × chain (trusted collaboration) × finance (RWA). Based on unified rules and standards, it achieves end-to-end capabilities with “four capabilities”: ownership confirmation, allocation, auditability, and interconnectivity. The entire value chain, from generation to recording to settlement, is transparent and traceable, enabling cross-domain collaboration, truly achieving an upgrade from “things to value.”
Graphene technology: a new material foundation for health applications
As one of the most disruptive materials of the 21st century, graphene is widely used in the field of health due to its ultra-high conductivity, excellent biocompatibility and sensitive sensing ability.
GNM combines graphene technology with sensors and wearable devices to achieve accurate monitoring and real-time collection of vital signs. For example:
Highly sensitive blood sugar and blood pressure monitoring is achieved through graphene sensors;
Integrating graphene chips into wearable devices to improve energy efficiency and data security;
Combined with the public chain, it ensures that every piece of original health data can be recorded reliably and cannot be tampered with.
This means that graphene is not just a material, but also the “physical entrance” that drives GNM to build a trusted health data base.
Public chain empowerment: building a trustworthy and shared health network
As a public chain for the life and health industry, the core design of GNM lies in decentralization and traceability.
Decentralized property rights confirmation: Individual users’ health data and personal care behaviors will no longer rely on a single institution for storage, but will be confirmed through distributed ledgers, truly realizing “data ownership by individuals”.
Smart contract execution：The recording, value settlement and equity distribution of nursing services are all automatically executed through smart contracts to ensure transparency, fairness and non-tamperability.
Design for interoperability: GNM is connected with existing big health information systems and wearable device platforms, breaking the traditional “data silos” and promoting the flow of health data across institutions and regions.
This makes GNM not only a technology public chain, but also a healthy trust network centered on .
RWA (Real World Assets): A New Paradigm for Building Health Value
In the global financial and blockchain markets, RWA is becoming a new and rapidly developing sector. Its core is to digitize real-world assets and map them to the blockchain, thereby improving liquidity and transparency.
In the GNM ecosystem, the application of RWA will directly affect the life and health industry:
Health data assetization: Individuals’ long-term health data, personal care records, etc. can be authenticated and transformed into assets, giving individuals value in the health network;
Big health service certificate: The resources of service providers such as large health enterprises can enter the transaction and circulation links in the form of on-chain certificates, improving service efficiency;
Financialization of Green Health: GNM will promote health-oriented green financial products, such as health data bonds and health points certificates, so that personal health behaviors can be directly converted into economic value.
Through RWA, GNM transforms life and health from a “spending-based industry” to a “value-creating industry.”
Reshaping the life and health value network
GNM’s mission is to replace information silos and artificial barriers with trusted rules, making every healthcare care and every interaction the starting point for value creation and fair distribution.
For individuals：Health data returns to personal sovereignty, and contributions in the health care process are visualized and valued.
For institutions: Improve service trust and resource allocation efficiency through on-chain transparency mechanisms.
For the industry：The combination of graphene × public chain × RWA opens up a new model of sustainable and scalable health value.
In the future, GNM will use decentralized networks as its foundation, graphene sensors and wearable devices as its entry point, and RWA as its value bridge to gradually build a future health blueprint that is user-centric, data-based, and oriented towards prevention and wellness.
Globalization strategy and ecological layout
The launch of GNM is just the beginning. The team has already planned a global strategic layout:
Multinational health cooperation：Cooperate with major health institutions in Asia, Europe and North America to promote the blockchainization of health data and cross-border collaboration.
Industrial alliance construction: Form an ecological alliance with wearable manufacturers, physical therapy companies, and insurance companies to jointly promote the practical application of graphene sensors and health data.
Financial market connection：Establish a docking mechanism with the financial platform of the RWA ecosystem, incorporate health assets into the global digital financial system, and enhance liquidity and value awareness.
Community-driven development：Through the DAO governance mechanism, we attract global users, health practitioners and investors to build, share and win together.
Health is an eternal concern for humanity, and technology is the driving force behind the evolution of health systems. The launch of GNM marks the official entry of the cross-border integration of blockchain, graphene, and RWA into the core arena of the life and health industry. It is more than just a public chain; it is a new health network that is people-centric, data-driven, and value-driven. In the future, GNM will focus on intelligence and openness to accelerate the digital transformation of the global health industry and reshape the value landscape of life and health.
Disclaimer: All news, information, and other content published on this website are provided by third-party brands or individuals and are for reference and informational purposes only. They do not constitute any investment advice or other commercial advice. For matters involving investment, finance, or digital assets, readers should make their own judgments and assume all risks. This website and its operators shall not be liable for any direct or indirect losses arising from reliance on or use of the content published herein.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No journalist was involved in the writing and production of this article.